{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T02:37:51Z","timestamp":1793587071336,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Project of the Traditional Chinese Medicine Administration of Hebei Province","award":["T2026074"],"award-info":[{"award-number":["T2026074"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-026-00869-0","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:52:08Z","timestamp":1771933928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Astragaloside IV represses the immune evasion and acidic microenvironment of oral squamous cell carcinoma"],"prefix":"10.1186","volume":"31","author":[{"given":"Wei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yameng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"10","key":"869_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-073375","volume":"13","author":"Z Lu","year":"2023","unstructured":"Lu Z, Zhou X, Fu L, Li Y, Tian T, Liu Q, et al. Prognostic prediction models for oropharyngeal squamous cell carcinoma (OPSCC): a protocol for systematic review, critical appraisal and meta-analysis. BMJ Open. 2023;13(10):e073375.","journal-title":"BMJ Open"},{"key":"869_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1203439","volume":"13","author":"A Michcik","year":"2023","unstructured":"Michcik A, Polcyn A, Sikora M, Wach T, Garbacewicz \u0141, Drogoszewska B. Oral squamous cell carcinoma - do we always need elective neck dissection? Evaluation of clinicopathological factors of greatest prognostic significance: a cross-sectional observational study. Front Oncol. 2023;13:1203439.","journal-title":"Front Oncol"},{"key":"869_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1228985","volume":"14","author":"Y Xi","year":"2023","unstructured":"Xi Y, Gao L, Li S, Sun K, Chen P, Cai Z, et al. The role of novel programmed cell death in head and neck squamous cell carcinoma: from mechanisms to potential therapies. Front Pharmacol. 2023;14:1228985.","journal-title":"Front Pharmacol"},{"issue":"4","key":"869_CR4","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1142\/S0192415X25500405","volume":"53","author":"J Ran","year":"2025","unstructured":"Ran J, Ai Y, Ni J, Zhang Y, Chen J, Wang T, et al. Astragaloside IV: a promising drug to prevent the transition from colitis to colorectal cancer. Am J Chin Med. 2025;53(4):1065\u201391.","journal-title":"Am J Chin Med"},{"key":"869_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1636341","volume":"16","author":"C Hu","year":"2025","unstructured":"Hu C, Li Q, Gong SN, Zou XJ, Xu JY, Ying HF, et al. Astragaloside IV: a potential nemesis for gastric cancer. Front Pharmacol. 2025;16:1636341.","journal-title":"Front Pharmacol"},{"issue":"24","key":"869_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413426","volume":"25","author":"K Yu","year":"2024","unstructured":"Yu K, Tang Y, Wang C, Liu W, Hu M, Hu A, et al. The astragalus membranaceus herb attenuates leukemia by inhibiting the FLI1 oncogene and enhancing anti-tumor immunity. Int J Mol Sci. 2024;25(24):13426.","journal-title":"Int J Mol Sci"},{"key":"869_CR7","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jare.2025.01.021","volume":"77","author":"Y Cui","year":"2025","unstructured":"Cui Y, Liu J, Wang X, Wu Y, Chang Y, Hu X, et al. Baicalin attenuates the immune escape of oral squamous cell carcinoma by reducing lactate accumulation in tumor microenvironment. J Adv Res. 2025;77:721\u201332.","journal-title":"J Adv Res"},{"issue":"1","key":"869_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22173-5","volume":"12","author":"M Shang","year":"2021","unstructured":"Shang M, Yang H, Yang R, Chen T, Fu Y, Li Y, et al. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. Nat Commun. 2021;12(1):1940.","journal-title":"Nat Commun"},{"issue":"29","key":"869_CR9","doi-asserted-by":"publisher","first-page":"E5986","DOI":"10.1073\/pnas.1706778114","volume":"114","author":"LX Liao","year":"2017","unstructured":"Liao LX, Song XM, Wang LC, Lv HN, Chen JF, Liu D, et al. Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy. Proc Natl Acad Sci USA. 2017;114(29):E5986\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"47","key":"869_CR10","doi-asserted-by":"publisher","first-page":"15044","DOI":"10.1002\/anie.201709584","volume":"56","author":"K Cheng","year":"2017","unstructured":"Cheng K, Lee JS, Hao P, Yao SQ, Ding K, Li Z. Tetrazole-based probes for integrated phenotypic screening, affinity-based proteome profiling, and sensitive detection of a cancer biomarker. Angew Chem Int Ed Engl. 2017;56(47):15044\u20138.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7","key":"869_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.01.002","volume":"14","author":"Q Jia","year":"2024","unstructured":"Jia Q, Zhou Y, Song L, Shi X, Jiang X, Tao R, et al. Baicalin reduces chronic stress-induced breast cancer metastasis via directly targeting \u03b22-adrenergic receptor. J Pharma Anal. 2024;14(7):100934.","journal-title":"J Pharma Anal"},{"issue":"47","key":"869_CR12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2208886119","volume":"119","author":"T Iizuka","year":"2022","unstructured":"Iizuka T, Yin P, Zuberi A, Kujawa S, Coon JSt, Bj\u00f6rvang RD, et al. Mono-(2-ethyl-5-hydroxyhexyl) phthalate promotes uterine leiomyoma cell survival through tryptophan-kynurenine-AHR pathway activation. Proc Natl Acad Sci USA. 2022;119(47):e2208886119.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"869_CR13","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41418-019-0423-5","volume":"27","author":"W Zhao","year":"2020","unstructured":"Zhao W, Cui Y, Liu L, Qi X, Liu J, Ma S, et al. Splicing factor derived circular RNA circUHRF1 accelerates oral squamous cell carcinoma tumorigenesis via feedback loop. Cell Death Differ. 2020;27(3):919\u201333.","journal-title":"Cell Death Differ"},{"issue":"2","key":"869_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/toxres\/tfaf047","volume":"14","author":"Y Zeng","year":"2025","unstructured":"Zeng Y, Duan T, Huang J, Wang X. Astragaloside IV inhibits nasopharyngeal carcinoma progression by suppressing the SATB2\/Wnt signaling axis. Toxicol Res. 2025;14(2):tfaf047.","journal-title":"Toxicol Res"},{"issue":"4","key":"869_CR15","doi-asserted-by":"publisher","DOI":"10.4081\/ejh.2024.4098","volume":"68","author":"T Wu","year":"2024","unstructured":"Wu T, Wu S, Gao H, Liu H, Feng J, Yin G. Astragaloside IV augments anti-PD-1 therapy to suppress tumor growth in lung cancer by remodeling the tumor microenvironment. Eur J Histochem. 2024;68(4):4098.","journal-title":"Eur J Histochem"},{"issue":"1","key":"869_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14758-w","volume":"25","author":"X Gao","year":"2025","unstructured":"Gao X, Hao W, Wang Y, Wu X, Zhu F, Zhang Y. Molecular mechanisms of astragaloside-IV in hepatocellular carcinoma therapy: a systematic review. BMC Cancer. 2025;25(1):1407.","journal-title":"BMC Cancer"},{"key":"869_CR17","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.2147\/DDDT.S520323","volume":"19","author":"Y Li","year":"2025","unstructured":"Li Y, Ma Y, Yao L, Li J, Zhou X, Wang M, et al. A review of the mechanisms of astragaloside IV and berberine in vascular dysfunction associated with obesity and diabetes. Drug Des Dev Ther. 2025;19:4911\u201332.","journal-title":"Drug Des Dev Ther"},{"key":"869_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118444","volume":"333","author":"J Yang","year":"2024","unstructured":"Yang J, Gao Y, Mao H, Kuang X, Tian F. Qiju dihuang pill protects the lens epithelial cells via alleviating cuproptosis in diabetic cataract. J Ethnopharmacol. 2024;333:118444.","journal-title":"J Ethnopharmacol"},{"key":"869_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116699","volume":"316","author":"HB Xu","year":"2023","unstructured":"Xu HB, Chen XZ, Wang X, Pan J, Yi-Zhuo Z, Zhou CH. Xihuang pill in the treatment of cancer: TCM theories, pharmacological activities, chemical compounds and clinical applications. J Ethnopharmacol. 2023;316:116699.","journal-title":"J Ethnopharmacol"},{"key":"869_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116358","volume":"316","author":"Y You","year":"2023","unstructured":"You Y, Chen X, Chen X, Li H, Zhou R, Zhou J, et al. Jiawei yanghe decoction suppresses breast cancer by regulating immune responses via JAK2\/STAT3 signaling pathway. J Ethnopharmacol. 2023;316:116358.","journal-title":"J Ethnopharmacol"},{"key":"869_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116134","volume":"306","author":"T Pei","year":"2023","unstructured":"Pei T, Dai Y, Tan X, Geng A, Li S, Gui Y, et al. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS(2) technology. J Ethnopharmacol. 2023;306:116134.","journal-title":"J Ethnopharmacol"},{"issue":"Pt 2","key":"869_CR22","volume":"319","author":"Q Ye","year":"2023","unstructured":"Ye Q, Lin B, Xu P, Zhang F, Wang N, Shou D. Yunvjian decoction attenuates lipopolysaccharide-induced periodontitis by suppressing NF\u03baB\/NLRP3\/IL-1\u03b2 pathway. J Ethnopharmacol. 2023;319(Pt 2):117279.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"869_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13020-025-01152-8","volume":"20","author":"H Hua","year":"2025","unstructured":"Hua H, Tang JY, Zhao JN, Wang T, Zhang JH, Yu JY, et al. From traditional medicine to modern medicine: the importance of TCM regulatory science (TCMRS) as an emerging discipline. Chinese Med. 2025;20(1):92.","journal-title":"Chinese Med"},{"key":"869_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119873","volume":"348","author":"X Dai","year":"2025","unstructured":"Dai X, Yang J, Ye Y, Wang C, Liu Y, Zhang M, et al. Bioactive components and mechanisms of the traditional Chinese herbal formula Xuefu zhuyu formula in the treatment of cardiovascular and cerebrovascular diseases. J Ethnopharmacol. 2025;348:119873.","journal-title":"J Ethnopharmacol"},{"key":"869_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156972","volume":"145","author":"R Shi","year":"2025","unstructured":"Shi R, Chan SI, Jin H, Li W, Zhang L, Yang J, et al. Jiegeng gancao decoction ameliorates ulcerative colitis: an integrative approach combining network pharmacology and proteomics via in silico and in vivo studies. Phytomedicine. 2025;145:156972.","journal-title":"Phytomedicine"},{"issue":"9","key":"869_CR26","first-page":"2334","volume":"50","author":"LH Yang","year":"2025","unstructured":"Yang LH, Liu J, Liang L, Lin J. Research progress of traditional Chinese medicine in regulating \u201cinflammation-cancer\u201d transformation in gastric mucosa based on NLRP3 inflammasome. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2025;50(9):2334\u201348.","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica"},{"key":"869_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112774","volume":"255","author":"J Wang","year":"2020","unstructured":"Wang J, Wang S, Wang Y, Wang L, Xia Q, Tian Z, et al. Chemopreventive effect of modified zengshengping on oral cancer in a hamster model and assessment of its effect on liver. J Ethnopharmacol. 2020;255:112774.","journal-title":"J Ethnopharmacol"},{"key":"869_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/15347354221134921","volume":"21","author":"PY Hsu","year":"2022","unstructured":"Hsu PY, Chen JL, Kuo SL, Wang WL, Jan FW, Yang SH, et al. San-zhong-kui-jian-tang exerts antitumor effects associated with decreased cell proliferation and metastasis by targeting ERK and the epithelial-mesenchymal transition pathway in oral cavity squamous cell carcinoma. Integr Cancer Ther. 2022;21:15347354221134921.","journal-title":"Integr Cancer Ther"},{"issue":"43","key":"869_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022955","volume":"99","author":"D Wang","year":"2020","unstructured":"Wang D, Duan X, Zhang Y, Meng Z, Wang J. Traditional Chinese medicine for oral squamous cell carcinoma: a Bayesian network meta-analysis protocol. Medicine (Baltimore). 2020;99(43):e22955.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"869_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010264","volume":"15","author":"X Wang","year":"2022","unstructured":"Wang X, Chen Z, Li B, Fan J, Xu W, Xiao J. Immunotherapy as a promising option for the treatment of advanced chordoma: a systemic review. Cancers. 2022;15(1):264.","journal-title":"Cancers"},{"key":"869_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109638","volume":"115","author":"T Yan","year":"2023","unstructured":"Yan T, Yu L, Shangguan D, Li W, Liu N, Chen Y, et al. Advances in pharmacokinetics and pharmacodynamics of PD-1\/PD-L1 inhibitors. Int Immunopharmacol. 2023;115:109638.","journal-title":"Int Immunopharmacol"}],"container-title":["Cellular & Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-026-00869-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00869-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00869-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:57:42Z","timestamp":1774965462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11658-026-00869-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["869"],"URL":"https:\/\/doi.org\/10.1186\/s11658-026-00869-0","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal protocol and details in present study had been conducted in accordance with the ethical principles and guidelines of the International Council for Laboratory Animal Science (ICLAS). This study was approved by the Ethics Committee of Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College (approval no. IRM2-IACUC-2505-015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consents for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}